Peering Into Quest Diagnostics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Quest Diagnostics (NYSE:DGX) has seen a 16.83% decrease in short interest, now at 2.55 million shares or 2.62% of float, with a 3.49-day average to cover. This decline in short interest could indicate a more bullish sentiment towards DGX compared to its peers, where the average short interest as a percentage of float is 10.14%.

April 24, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Quest Diagnostics has experienced a significant decrease in short interest, suggesting a potential increase in bullish sentiment among investors.
A decrease in short interest typically indicates that investors are less bearish on the stock, potentially leading to an increase in its price in the short term. Given that DGX's short interest is significantly lower than its peer group average, this could be seen as a positive signal by the market.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100